Cargando…
TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas
TERT promoter mutations are identified in many malignancies including bladder cancer (BC) and upper tract urothelial carcinoma (UTUC). In contrast, no mutations were found in renal cell carcinoma (RCC) as reported in a recent study. Because the mutant TERT promoter in urine DNA was recently tested a...
Autores principales: | Wang, Kun, Liu, Tiantian, Liu, Li, Liu, Jikai, Liu, Cheng, Wang, Chang, Ge, Nan, Ren, Hongbo, Yan, Keqiang, Hu, Sanyuan, Björkholm, Magnus, Fan, Yidong, Xu, Dawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039120/ https://www.ncbi.nlm.nih.gov/pubmed/24742867 |
Ejemplares similares
-
TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR
por: Wang, Kun, et al.
Publicado: (2014) -
Regulatory region mutations of TERT, PLEKHS1 and GPR126 genes as urinary biomarkers in upper tract urothelial carcinomas
por: Xing, Xiangling, et al.
Publicado: (2021) -
The association between the TERT rs2736100 AC genotype and reduced risk of upper tract urothelial carcinomas in a Han Chinese population
por: Yuan, Xiaotian, et al.
Publicado: (2016) -
The genetic difference between Western and Chinese urothelial cell carcinomas: infrequent FGFR3 mutation in Han Chinese patients
por: Yuan, Xiaotian, et al.
Publicado: (2016) -
TERT promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance
por: Liu, Tiantian, et al.
Publicado: (2023)